It was a pretty good day on Wall Street on Tuesday. Only in the last hour did they pull back a little bit on profit taking. Lot of stocks acted very well, so it’s a long list of stocks on the chart, but we will do our usual four highlights here.
Amicus Therapeutics, Inc. (NASDAQ:FOLD), one of our swing trades, is acting great. It had another follow-through day on Tuesday, up 37 cents to 15.07, or 2.5%, on 2 million shares. Once it accelerates, expect it to get up to 16, then 18 1/2, and maybe a lot more than that. Mid-channel is 22 and the top of the channel is at 26-7. But we're not there yet.
MiMedx Group, Inc. (NASDAQ:MDXG) has been just great, especially long term. It was up 64 cents to 12.75, or 5.2%, on 4.4 million shares on Tuesday. Look for a consolidation and a retest of 12-12 1/4. If it gets through that, maybe we will be able to set the target at 16.
PowerSecure International, Inc. (NYSE:POWR) was up 37 cents to 16.09, or 2.35%, on 263,500. It broke out, pulled back, we put a swing on it, and it had another good day on Tuesday, holding support at 15-15.75, and resistance around 17. If it gets through that, look for 18 3/4.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is looking good, up 17 cents to 18.47, or 1%, on 700,000 shares on an inside positive day on Tuesday. The double-top around 18.65 is the first target. If it gets through that, look for 20 1/2-3/4, and then 24-25.
Other stocks on Harry’s Charts of the Day included Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), Cempra, Inc. (NASDAQ:CEMP), Celldex Therapeutics, Inc. (NASDAQ:CLDX), EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), Exact Sciences Corporation (NASDAQ:EXAS), Fitbit Inc (NYSE:FIT), Halozyme Therapeutics, Inc. (NASDAQ:HALO), ImmunoGen, Inc. (NASDAQ:IMGN), JetBlue Airways Corporation (NASDAQ:JBLU), Novavax, Inc. (NASDAQ:NVAX), MOBILEYE N.V. (NYSE:MBLY), Medx Group, Inc. (NASDAQ:MDXG), NewLink Genetics Corporation (NASDAQ:NLNK), Novavax, Inc. (NASDAQ:NVAX), Northwest Biotherapeutics, Inc. (NASDAQ:NWBO), and Radius Health, Inc. (NASDAQ:RDUS), Retrophin, Inc. (NASDAQ:RTRX), Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP), SunEdison, Inc. (NYSE:SUNE), Synthetic Biologics Inc. (NYSE:SYN), Teladoc, Inc. (TDOC), and ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP).